These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 36868843)

  • 21. Hashimotos thyroiditis.
    Hamous J; Dvořák J; Bušovský I; Šnajdr M
    Rozhl Chir; 2021; 100(3):110-112. PubMed ID: 33910355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
    Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
    Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
    Zervou FN; Louie P; Stachel A; Zacharioudakis IM; Ortiz-Mendez Y; Thomas K; Aguero-Rosenfeld ME
    J Med Virol; 2021 Sep; 93(9):5409-5415. PubMed ID: 33932299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients.
    Wang H; Yan D; Li Y; Gong Y; Mai Y; Li B; Zhu X; Wan X; Xie L; Jiang H; Zhang M; Sun M; Yao Y; Zhu Y
    Infect Dis Poverty; 2022 Feb; 11(1):15. PubMed ID: 35109926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against SARS-CoV-2 S and N proteins in relapsing-remitting multiple sclerosis patients treated with disease-modifying therapies.
    Kulikowska J; Czarnowska A; Gudowska-Sawczuk M; Kulczyńska-Przybik A; Bazylewicz M; Collins F; Chorąży M; Mroczko B; Kochanowicz J; Kapica-Topczewska K; Kułakowska A
    Neurol Neurochir Pol; 2023; 57(1):121-130. PubMed ID: 36421067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term evolution of humoral immune response after SARS-CoV-2 infection.
    Teyssou E; Zafilaza K; Sayon S; Marot S; Dropy M; Soulie C; Abdi B; Tubach F; Hausfater P; Marcelin AG; Boutolleau D;
    Clin Microbiol Infect; 2022 Jul; 28(7):1027.e1-1027.e4. PubMed ID: 35307573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
    Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A; Sano K; Saito S; Shiwa-Sudo N; Nagata N; Tamura K; Suzuki R; Hasegawa H; Suzuki T
    Vaccine; 2022 Sep; 40(41):5892-5903. PubMed ID: 36064667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
    Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
    Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of IgM, IgG, IgA and neutralizing antibody responses to SARS-CoV-2 infection and mRNA vaccination.
    Fleischmann CJ; Bulman CA; Yun C; Lynch KL; Wu AHB; Whitman JD
    J Med Microbiol; 2023 Jan; 72(1):. PubMed ID: 36748419
    [No Abstract]   [Full Text] [Related]  

  • 31. SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals.
    Ruggiero A; Piubelli C; Calciano L; Accordini S; Valenti MT; Carbonare LD; Siracusano G; Temperton N; Tiberti N; Longoni SS; Pizzato M; Accordini S; ; Fantoni T; Lopalco L; Beretta A; Bisoffi Z; Zipeto D
    EBioMedicine; 2022 Mar; 77():103888. PubMed ID: 35196644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
    Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K
    PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.
    Cohen DE; Sibbel S; Marlowe G; Bludorn K; Miller D; Kelley T; Connaire J; Young A; Tentori F; Brunelli SM
    J Am Soc Nephrol; 2021 Aug; 32(8):1880-1886. PubMed ID: 34215666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects.
    Martinuzzi E; Benzaquen J; Guerin O; Leroy S; Simon T; Ilie M; Hofman V; Allegra M; Tanga V; Michel E; Boutros J; Maniel C; Sicard A; Glaichenhaus N; Czerkinsky C; Blancou P; Hofman P; Marquette CH
    Clin Infect Dis; 2022 Dec; 75(12):2053-2059. PubMed ID: 35579991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.
    Quinti I; Locatelli F; Carsetti R
    Front Immunol; 2021; 12():815404. PubMed ID: 35126372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of endometriosis 1st part - Overview of diagnostic approaches.
    Indrielle-Kelly T; Frühauf F; Burgetová A; Fanta M; Fischerová D
    Ceska Gynekol; 2019; 84(4):252-259. PubMed ID: 31818107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Response of Neonates Born to Mothers Infected With SARS-CoV-2.
    Conti MG; Terreri S; Piano Mortari E; Albano C; Natale F; Boscarino G; Zacco G; Palomba P; Cascioli S; Corrente F; Capponi C; Mirabella M; Salinas AF; Marciano A; De Luca F; Pangallo I; Quaranta C; Alteri C; Russo C; Galoppi P; Brunelli R; Perno CF; Terrin G; Carsetti R
    JAMA Netw Open; 2021 Nov; 4(11):e2132563. PubMed ID: 34730817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-lasting T-cell response to SARS-CoV-2 antigens after vaccination-a prospective cohort study of HCWs working with COVID-19 patients.
    Krifors A; Freyhult E; Rashid Teljebäck M; Wallin RPA; Winqvist O; Månsson E
    Infect Dis (Lond); 2023 Feb; 55(2):142-148. PubMed ID: 36369711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response following infection with SARS-CoV-2 and other coronaviruses: A rapid review.
    O Murchu E; Byrne P; Walsh KA; Carty PG; Connolly M; De Gascun C; Jordan K; Keoghan M; O'Brien KK; O'Neill M; Smith SM; Teljeur C; Ryan M; Harrington P
    Rev Med Virol; 2021 Mar; 31(2):e2162. PubMed ID: 32964627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.